BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/EPHB3/Compounds

Compounds That Target EPHB3

EPH receptor B3 · 16 compounds in BiohacksAI corpus

EPHB3 (EPH receptor B3) is a biological target with 16 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into EPHB3 modulation for therapeutic and biohacking applications.

View EPHB3 target page →UniProt: P54753 ↗
Most Studied Compounds for EPHB3
1
Dasatinib
299+
studies
All 16 Compounds — Ranked by Evidence
1
Foretinib
4.34
confidence
2
Ponatinib
4.26
confidence
3
Nilotinib
4.17
confidence
4
Bosutinib
4.08
confidence
5
Doramapimod
4.06
confidence
6
Tae 684
3.43
confidence
7
Linifanib
3.33
confidence
8
Mln 8054
3.33
confidence
9
Dasatinib Anhydrous
3.09
confidence
10
Danusertib
2.94
confidence
11
Milciclib
2.77
confidence
12
Tivozanib
2.64
confidence
13
Golvatinib
2.20
confidence
14
Asp 3026
2.08
confidence
15
Bafetinib
1.95
confidence
16
Dasatinib
299+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for EPHB3 (EPH receptor B3). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: EPHB3 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.